Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Researchers with the ongoing, multinational Semaglutide Effects on Cardiovascular Outcomes in Patients With Overweight or Obesity (SELECT) trial randomly assigned 17,604 participants aged 45 years or older who were overweight or obese and had cardiovascular disease but not diabetes to receive a weekly injection of 2.4 milligrams of semaglutide or a placebo
Well break down how these drugs compare, what they cost, and what to expect from each so that you can make the best choice for your health goals
Research is limited: study protocols do not equal self-use instructions
No algebra, no calculator needed
At the maximum tolerated dose, hair loss occurred in 8.3% of people on Zepbound and 6.1% on Wegovy
They reduce caspase-3 mRNA activity and enhance the expression of anti-apoptotic genes, including Bcl-2 and Bcl-xl [45, 46]
